Hpv Infections clinical trials

Explore recruiting hpv infections clinical trials.

Recruiting hpv infections studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hpv Infections trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, placebo-controlled, double-blind study to evaluate 2LPAPI® efficacy on the clearance of genital HR-HPV infections (PAPION study)

Belgium, Romania

Therapeutic use (Phase IV) EU CTIS Study details

Developing a first-void urine-based infection model to study HPV-specific antibody-virion interaction before and after vaccination with the Gardasil-9 HPV vaccine – a non-randomized open-label study.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy of pre-surgical HPV9-valente vaccination in women treated with loop electrosurgical excision (LEEP) for high-grade cervical intraepithelial neoplasia (CIN2+) up to cervical cancer initially invasive (FIGO IA1) - HOPE 9 STUDY

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Human papillomavirus vaccine effectiveness study among men who have sex with men

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Prospective longitudinal study on immunogenicity, induction of cellular immune responses and safety of vaccination against HPV with the 9valent vaccine in HIV-positive women The Papillon study

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Hpv Infections trials by city

Hpv Infections in Toronto Hpv Infections in Vancouver Hpv Infections in Montreal Hpv Infections in Calgary Hpv Infections in Edmonton Hpv Infections in Ottawa Hpv Infections in Winnipeg Hpv Infections in Quebec City Hpv Infections in Hamilton Hpv Infections in Kitchener Hpv Infections in London Hpv Infections in Halifax Hpv Infections in New York Hpv Infections in Los Angeles Hpv Infections in Chicago Hpv Infections in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease